Print Page     Close Window     

SEC Filings

20-F
AC IMMUNE SA filed this Form 20-F on 03/21/2019
Entire Document
 

CONFIDENTIAL TREATMENT REQUESTED UNDER RULE 24B-2
UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED.

 

[*****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE COMMISSION.

 

Co-Promotion Agreement Section ‎4.7.3
Co-Promotion Indication Section ‎4.7.1
Co-Promotion Option Section ‎4.7.1
Development Plan Section ‎3.1.2
Diligence Products Section ‎3.1.3
Dispute Section ‎13.5
DOJ Section ‎1.55
Elected Percentage Section ‎7.6.4
Eligible Indication Section ‎3.2.1
Eligible Product Section ‎3.2.1
Exclusion Percentage Section ‎1.96
Exclusive Co-Promotion Indication Section ‎4.7.1
Execution Date Preamble
Existing Patents Section ‎10.2.2
FTC Section ‎1.55
Government Official Section ‎10.4.2
Indemnification Claim Notice Section ‎11.3.1
Indemnified Party Section ‎11.3.1
Infringement Section ‎8.3.1

 

 16


© AC Immune 2015